Upper Tract Surgery

Introduction {#s0005}
============

Renal transplantation improves both the quantity and quality of life for recipients [@b0005]. Worldwide \>40% of the ∼69 000 kidney transplants carried out in 2008 were from live donors [@b0010]. Live-donor nephrectomies (DNs) are more cost effective [@b0015] and offer superior graft survival particularly in the longer term [@b0020], [@b0025]. When carefully screened, healthy kidney donors have been shown to have no increased risk of developing end-stage renal disease than the average population [@b0030].

Laparoscopic DN (LDN) was introduced in 1995 by Ratner et al. [@b0035], with lower postoperative pain, quicker recovery time, shorter hospital stay, and better cosmesis [@b0040]. LDN has become the reference standard for DN for these reasons and has been shown to increase recruitment of live donors [@b0045], [@b0050]. However, some of the earlier studies raised questions over the safety of the procedure due to intraoperative events, so hand-assisted LDN (HALDN) was introduced in 1998 as an alternative technique [@b0055]. This enabled a combination of the minimally invasive approach with tactile feedback and immediate control of the hilum should intraoperative bleeding occur. The learning curve associated with HALDN was another advantage over LDN [@b0060].

Both LDN and HALDN techniques have been shown to have advantages over the open procedure [@b0065], [@b0070], [@b0075]. However, the superiority of one technique over another is still not entirely clear when it comes to technical variations in LDN. Similarly, for the hand-assisted technique there have been few studies directly comparing the transperitoneal and retroperitoneal approaches and no randomised controlled trial (RCT) in this area.

In 2007, a systematic review and meta-analysis of nine studies comparing 174 LDN and 202 HALDN procedures found that HALDN had a lower rate of conversion to an open procedure (2.97% vs 4.6%), a shorter warm ischaemia time (WIT) and length of procedure, as well as lower blood loss than LDN [@b0080]. According to another review, HALDN trended towards a lower intraoperative complication rate and increased minor postoperative complications than LDN [@b0085]. A qualitative review of evidence in 2010 found that most studies comparing different minimal invasive techniques were similar in terms of intra- and postoperative outcome for both the donor and the recipient [@b0075]. Wadstrom et al. [@b0090] carried out a systematic review and meta-analysis comparing traditional open DN to pure LDN and HALDN methods in 2011. This covered 30 original articles relating to DN but also included 21 articles concerning radical nephrectomy and 14 nephroureterectomy.

Since 2007 there has been at least nine further studies comparing LDN to HALDN or hand-assisted retroperitoneal DN (HARPDN), including three RCTs. Therefore, an updated analysis of the outcomes for these procedures is warranted.

Methods {#s0010}
=======

Study design {#s0015}
------------

A systematic review of RCTs, as well as prospective and retrospective cohort studies, was carried out using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist [@b0095].

Search strategy {#s0020}
---------------

The keywords 'donor nephrectomy', 'laparoscopic', and 'hand-assisted laparoscopic' were entered into databases including PubMed, Embase, Web of Science and Cochrane. The dates covered were from 1 January 1995 to 31 December 2014. The search was limited to published studies on humans, with no limits on language. The lists of references of relevant primary research and review articles were searched for further studies. Authors were contacted to provide further information from their studies where necessary.

Eligibility criteria {#s0025}
--------------------

RCTs, prospective and retrospective cohort studies comparing the purely LDN to either transperitoneoscopic or retroperitoneoscopic hand-assisted techniques reported in a single cohort were included. Non-comparative studies or those that compared to another technique were excluded, also where no full text was available. When more than one study containing the same population of patients was reported from the same institution the most recent publication was included. The primary outcome was conversion to an open procedure. Other secondary outcome measures included WIT (the time from cross clamping of the renal artery until cold perfusion), operation time (OT), estimated blood loss (EBL), complications (both intra- and postoperative), and length of stay (LOS).

Study selection {#s0030}
---------------

If the title of the article appeared to address the inclusion criteria the abstract was reviewed by two independent authors (M.P.B. and L.G.K.), then the full article if deemed eligible. Studies were included if they addressed any of the above-mentioned outcomes as either primary or secondary outcomes. If there was disagreement over the eligibility of a particular study, conclusion was reached by consensus agreement.

Data required {#s0035}
-------------

The data taken from each study included sample size, demographic data such as mean age, gender, mean body mass index (BMI), side of nephrectomy, as well as the outcomes mentioned above.

Quality assessment of methods {#s0040}
-----------------------------

The methodological quality of RCTs was assessed using the Cochrane risk of bias tool [@b0100]. For each category, a judgement of 'yes', 'no' or 'unclear' was given. The methodological quality of both retrospective and prospective cohort studies was assessed using the Newcastle-Ottawa Scale [@b0105]. A score of 0--9 (allocated as stars) was allocated to each of the cohort studies. A score of 0--3 stars was deemed low quality, 4--6 stars medium quality, and 7--9 stars were considered to be of high quality. Quality assessments were made by two independent reviewers (M.P.B. and L.G.K.).

Data synthesis and statistics {#s0045}
-----------------------------

'Review Manager' (Revman version 5.2 The Cochrane Collaboration, Oxford, UK) was used to perform meta-analysis of the data. Data were presented as odds ratios (ORs) for dichotomous and weighted mean differences (WMDs) for continuous variables with 95% CIs. For studies that presented continuous data as means and range values and where standard deviation (SD) was not available or not provided on contacting the authors, it was calculated using the range rule [@b0110]. Analysis was carried out separately for RCTs and cohort studies due to their different study designs. Subgroup analysis was performed to assess the retroperitoneal HARPDN technique. A fixed-effects model (FEM) was used for analysis, except when *I*^2^ was \>50% a random-effects model (REM) was used. Statistical heterogeneity was measured using chi-squared and *I*^2^ models [@b0115]. Sensitivity analysis was performed for studies performed in 2010 or later.

Results {#s0050}
=======

Included studies {#s0055}
----------------

The literature search yielded 1003 citations. A further six were obtained from other sources, such as reference lists of other studies, and there were 11 duplicates. Overall, 77 full text articles were assessed for eligibility, with studies excluded for the reasons listed below ([Fig. 1](#f0005){ref-type="fig"}). In total, there were 24 included studies, three RCTs, one randomised pilot study, two prospective and 18 retrospective cohort studies.Fig. 1PRISMA flow chart for study selection.

Included studies characteristics {#s0060}
--------------------------------

The characteristics of the included studies are summarised in the table below ([Table 1](#t0005){ref-type="table"}) [@b0120], [@b0125], [@b0130], [@b0135], [@b0140], [@b0145], [@b0150], [@b0155], [@b0160], [@b0165], [@b0170], [@b0175], [@b0180], [@b0185], [@b0190], [@b0195], [@b0200], [@b0205], [@b0210], [@b0215], [@b0220], [@b0225], [@b0230], [@b0235]. Good geographic distribution of participants was seen, with studies mainly from Northern Europe/Scandinavia, South Asia, and USA. There was a wide range in the number of study participants. Only five studies had \>200 participants, whilst 12 studies had \<100 participants. All but one of the HARPDN studies, including both randomised studies, came from Northern Europe/Scandinavia illustrating the popularity of the technique in this region.Table 1Characteristics of the 24 included studies.ReferencesYearCountryType of studyTechniqueNo. of patientsBargman et al. [@b0120]2006USARCTHALDN vs LDN20 vs 20Branco et al. [@b0125]2008BrazilRetrospective cohortHALDN vs LDN67 vs 89Buell et al. [@b0130]2004USAProspective cohortHALDN vs RLDN31 vs 28Cho et al. [@b0135]2013KoreaRCTHALDN vs LDN50 vs 50Choi et al. [@b0140]2014KoreaRetrospective cohortHALDN vs LDN80 vs 80Dols et al. [@b0145]2014NetherlandsRCTHARP vs LDN95 vs 95El-Galley et al. [@b0150]2004UKRetrospective cohortHALDN vs LDN vs ODN55 vs 17 vs 28Gershbein et al. [@b0155]2002USARetrospective cohortHALDN vs LDN15 vs 30Gjertsen et al. [@b0160]2006USARetrospective cohortHARP vs LDN vs ODN11 vs 15 vs 25Klop et al. [@b0165]2014NetherlandsRandomised pilot studyHARP vs LDN20 vs 20Kocak et al. [@b0170]2007USARetrospective cohortHALDN vs LDN318 vs 482Lai et al. [@b0175]2010TaiwanRetrospective cohortHALDN vs LDN52 vs 45Lucas et al. [@b0180]2013USARetrospective cohortHALDN vs LDN116 vs 152Mateo et al. [@b0185]2003USARetrospective cohortHALDN vs LDN18 vs 29Mjøen et al. [@b0190]2010NorwayRetrospective cohortHALDN vs LDN vs HARPDN177 vs 196 vs 26Percegona et al. [@b0195]2008BrazilRetrospective cohortHALDN vs LDN34 vs 21Ruiz-Deya et al. [@b0200]2001USARetrospective cohortHALDN vs LDN vs ODN23 vs 11 vs 14Ruszat et al. [@b0205]2006SwitzerlandRetrospective cohortHALDN vs LDN vs RLDN vs ODN34 vs 14 vs 65 vs 69Salazar et al. [@b0210]2005CanadaRetrospective cohortHALDN vs LDN vs ODN24 vs 11 vs 15Sundqvist et al. [@b0215]2004SwedenProspective cohortHARPDN vs LDN vs. ODN11 vs 14 vs 11Ungbhakorn et al. [@b0220]2012ThailandRetrospective cohortHALDN vs LDN vs ODN23 vs 82 vs 95Velidedeoglu et al. [@b0225]2002USARetrospective cohortHALDN vs LDN vs ODN60 vs 40 vs 50Wadstrom et al. [@b0230]2003SwedenRetrospective cohortHALDN vs LDN vs HARPDN14 vs 11 vs 18Yoo et al. [@b0235]2006KoreaRetrospective cohortHALDN vs LDN vs ODN177 vs 24 vs 42[^1][^2][^3][^4]

Quality of studies summary {#s0065}
--------------------------

The quality of the randomised studies was assessed using the Cochrane Risk of Bias Tool. A summary can be found in the table below ([Table 2](#t0010){ref-type="table"}) [@b0120], [@b0135], [@b0145], [@b0165]. The two Dutch studies [@b0145], [@b0165] had a much lower risk of bias, particularly when it came to sequence generation, allocation concealment, and attempt at blinding. They also addressed incomplete outcomes more overtly. The other two studies Bargman et al. [@b0120] and Cho et al. [@b0135] both had a high risk of bias on overall assessment.Table 2Risk of bias assessment of randomised studies.Randomised studyAdequate sequence generation?Allocation concealment?Adequate blinding?Incomplete outcome data addressed?Free of selective reporting?Free of other bias?Dols et al. 2014 [@b0145]YesYesNo - singleYesYesYesKlop et al. 2014 [@b0165]YesYesNo - singleYesYesYesCho et al. 2013 [@b0135]UnclearNoNoNoUnclearUnclearBargman et al. 2006 [@b0120]UnclearNoNoNoUnclearUnclear

An assessment of the cohort studies was made using the Newcastle-Ottawa Scale and is summarised in the table below ([Table 3](#t0015){ref-type="table"}). The overall quality was medium (4--6 stars). Kocak et al. [@b0170], Mjøen et al. [@b0190] and Choi et al. [@b0140] were the three studies that were given a higher quality score (7--9 stars). All cohorts scored 3 on selection criteria. The outcomes were already present when the study began for all but two prospective cohort studies [@b0130], [@b0215]. Most studies had groups that were comparable in terms of age, gender and BMI. Those that were matched for side of nephrectomy, multiple renal arteries, and previous abdominal surgery, as well were given a higher rating. Most of the studies outlined the perioperative protocol and stated that both groups were exposed to the same protocol. Whilst duration of follow-up was stated in most studies, there is little direct information on completeness of follow-up on participants. Overall there was heterogeneity between studies in terms of the characteristics and number of participants, study methodology and follow-up.Table 3Quality assessment of cohort studies using the Newcastle-Ottawa Scale.ReferencesSelectionComparabilityOutcomeTotalRuiz-Deya et al. [@b0200]\*\*\*\*\*\*5Velidedeoglu et al. [@b0225]\*\*\*\*\*5Gershbein et al. [@b0155]\*\*\*\*\*\*6Wadstrom et al. [@b0230]\*\*\*\*\*5Mateo et al. [@b0185]\*\*\*\*\*\*\*6Sundqvist et al. [@b0215]\*\*\*\*\*\*6Buell et al. [@b0130]\*\*\*\*\*\*6El-Galley et al. [@b0150]\*\*\*\*\*5Salazar et al. [@b0210]\*\*\*\*\*5Gjertsen et al. [@b0160]\*\*\*\*\*5Yoo et al. [@b0235]\*\*\*\*\*5Ruszat et al. [@b0205]\*\*\*\*\*\*6Kocak et al. [@b0170]\*\*\*\*\*\*\*7Branco et al. [@b0125]\*\*\*\*\*\*6Percegona et al. [@b0195]\*\*\*\*4Lai et al. [@b0175]\*\*\*\*\*\*6Mjøen et al. [@b0190]\*\*\*\*\*\*\*7Ungbhakorn et al. [@b0220]\*\*\*\*\*5Lucas et al. [@b0180]\*\*\*\*\*\*6Choi et al. [@b0140]\*\*\*\*\*\*\*\*8[^5]

Meta-analysis {#s0070}
=============

Firstly, an overall analysis was carried out comparing hand-assisted (both HALDN and HARPDN) vs pure LDN.

RCTs {#s0075}
----

On analysis of the four randomised studies, there was a total of 370 patients; 185 in each group. There was one conversion in the hand-assisted group vs three in the laparoscopic group, OR 0.42 (FEM, 95% CI 0.06, 2.90) ([Fig. 2](#f0010){ref-type="fig"}). For secondary outcomes, WIT was significantly shorter in the hand-assisted group (76.58 s, 95% CI −111.76, −41.40) ([Fig. 3](#f0015){ref-type="fig"}). There was no statistically significant difference in OT (−5.36 min, 95% CI −22.85, 12.12), intraoperative complication rate (OR 0.55, 95% CI 0.22, 1.35,), or postoperative complication rate (OR 0.89, 95% CI 0.45, 1.75) ([Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}). There was no statistically significant difference between the two groups in EBL at 31.13 mL (REM, 95% CI −45.84, 108.09; *I*^2^ = 85%, *P* = 0.43), or LOS postoperatively at 0.16 days (FEM, 95% CI −0.06, 0.38; *I*^2^ = 0%, *P* = 0.14).Fig. 2Odds difference in open conversions between all HALDN (experimental) and pure LDN (control) procedures for RCTs.Fig. 3Mean difference in WIT between all HALDN (experimental) and pure LDN (control) procedures for RCTs.Fig. 4Mean difference in operation time between all HALDN (experimental) and pure LDN (control) procedures for RCTs.Fig. 5Odds difference in complications between all HALDN (experimental) and pure LDN (control) procedures for RCTs.

All hand-assisted vs laparoscopic pooled cohorts {#s0080}
------------------------------------------------

Overall, 20 cohort studies were analysed to compare hand-assisted techniques to pure LDN. The two hand-assisted techniques of HALDN and HARPDN were pooled for this analysis. Three cohort studies carried out more than one relevant comparison [@b0190], [@b0205], [@b0230], so these were included separately e.g. Mjøen et al. 2010a and Mjøen et al. 2010b [@b0190]. There was no statistical difference in conversions to open procedure between the two groups. In total, 26/1415 hand-assisted procedures were converted vs 27/1669 pure LDN procedures, OR 1.06 (95% CI 0.63, 1.78) ([Fig. 6](#f0030){ref-type="fig"}). Both WIT and OT were shorter in the hand-assisted group by −41.79 s (95% CI −71.85, −11.74) and −26.32 min (95% CI −40.67, −11.97), respectively ([Fig. 7](#f0035){ref-type="fig"}, [Fig. 8](#f0040){ref-type="fig"}). There was no difference in overall complications between the two groups OR 0.98 (95% CI 0.72, 1.32) ([Fig. 9](#f0045){ref-type="fig"}). Only 11 cohort studies assessed EBL. There was no statistically significant difference between the two groups in terms of EBL at −11.08 mL (REM, 95% CI −33.45, 11.28; *I*^2^ = 73%, *P* = 0.33), or LOS at 0.20 days (REM, 95% CI −0.11, 0.51; *I*^2^ = 95%, *P* = 0.2).Fig. 6Odds difference in open conversions between all HALDN (experimental) and pure LDN (control) procedures for pooled cohort studies.Fig. 7Mean difference in WIT between all HALDN (experimental) and pure LDN (control) procedures for pooled cohort studies.Fig. 8Mean difference operation time between all HALDN (experimental) and pure LDN (control) procedures for pooled cohort studies.Fig. 9Odds difference in complications between all HALDN (experimental) and pure LDN (control) procedures for pooled cohort studies.

Subgroup analysis --- HARPDN vs LDN cohorts {#s0085}
-------------------------------------------

A total of six studies compared specifically the retroperitoneal hand-assisted approach with pure LDN. This included one RCT, one randomised pilot study, one prospective cohort and four retrospective cohort studies. Only the cohorts were analysed in this subgroup. Out of a total of 305 patients, there were no conversions in the HARPDN group vs three LDN patients, OR 0.76 (FEM, 95% CI 0.08, 7.33; *I*^2^ = 0%, *P* = 0.81). Three studies assessed WIT, with a total of 279 patients. WIT was shorter in the HARPDN group at −54.78 s (REM, 95% CI −90.93, −18.63; *I*^2^ = 66%, *P* = 0.003), as was OT at −75.43 min (REM, 95% CI −121.81, −29.06; *I*^2^ = 95%, *P* = 0.001). There was a lower intraoperative events risk in the HARPDN group, OR 0.49 (FEM, 95% CI 0.05, 4.44; *I*^2^ = 0%, *P* = 0.53). On the other hand, postoperative complications were significantly higher in this group, OR 3.54 (FEM, 95% CI 1.55, 8.09; *I*^2^ = 0%, *P* = 0.003).

Sensitivity analysis {#s0090}
--------------------

There was statistical heterogeneity between the studies. A sensitivity analysis was performed for more recently published cohort studies. A cut-off of 2010 or later was used. For conversions to open procedure the OR reduced from 1.06 (FEM, 95% CI 0.63, 1.78; *I*^2^ = 0%, *P* = 0.84) to 0.65 (FEM, 95% CI 0.20, 2.14; *P* = 0.48), whilst *I*^2^ remained 0%, chi-squared reduced from 16.46 to 1.20. WIT increased from −41.79 s (REM, 95% CI −71.85, −11.74; *I*^2^ = 96%, *P* = 0.006) to −56.96 s (REM, 95% CI −87.09, −26.82; *P* \< 0.001). The chi-squared score reduced substantially from 424.78 to 36.87 and *I*^2^ reduced slightly from 96% to 89%. There was no significant change in OT, EBL, complications, and LOS. Overall there was less heterogeneity for the studies after 2010 for most outcomes, which is likely due to the established nature of each technique.

Discussion {#s0095}
==========

Statement of principal findings {#s0100}
-------------------------------

The present meta-analysis had conversions to an open procedure as the primary outcome and none of the analyses showed a statistically significant difference in conversion rates. Whilst conversion is not a complication in itself, it implies issues regarding technical difficulty and intraoperative safety and will have an effect on postoperative recovery. It has previously been shown in a large series that the most common reason for conversion is vascular injury (38.5%) and open conversion is inversely related to case volume and accumulated experience [@b0240].

There was a consistent difference in the secondary outcome of WIT, both overall and in the subgroup analysis. This is most likely due to the fact that the kidney is manually extracted through the handport quickly after the vessels are ligated in the hand-assisted approach, whilst the purely laparoscopic approach requires a retrieval bag and incision. There is limited long-term data relating to graft function in the setting of longer WITs. One study found similar survival rates but a trend towards reduced long-term function with longer WIT; however, this was in non-heart beating donors [@b0245]. An RCT of 200 patients found no difference in long-term graft function associated with longer WIT when comparing LDN to open DN [@b0250].

OT was shorter overall in the hand-assisted group, with over an hour reduction for the HARPDN subgroup. The duration of procedure is difficult to compare with certainty because the endpoint can vary amongst institutions and how it is measured is often not stated. Despite this possible confounder, we observed a wide range in OT for each technique (83--269 min for HALDN, 78.4--311 min for LDN). The variance in OT for HARPDN was much smaller 141--172 min. This suggests an effect of uniform recording, as well as certain centre-specific practices and operator experience.

There was little difference in the overall complication rate between the two groups. There were stricter rates of reporting of even very minor complications in certain centres [@b0145], [@b0165]. Whilst the intraoperative event rate was lower and the postoperative complications risk higher in the hand-assisted group, none of these were statistically significant. Based on the present meta-analysis LDN is as safe as HALDN and HARPDN. Finally, there was no statistically significant advantage in EBL or LOS between the techniques.

Results in the context of current literature {#s0105}
--------------------------------------------

Kokkinos et al. [@b0080] carried out a meta-analysis of nine cohort studies published in 2007. The present study has produced comparable results over 8 years later. Although not statistically significant, the conversion rate was lower in the Kokkinos et al. [@b0080] meta-analysis, OR 0.58 (95% CI 0.18, 1.82). The conversion rate in our present study is almost the same in both groups, OR 1.06. The advantage of hand-assisted of shorter WIT and OT has been shown in both the Kokkinos et al. [@b0080] and our present study. The present study reconfirms the evidence from Kokkinos et al. [@b0080] that there is no statistical difference in the complication rate between HALDN and LDN, although intraoperative complications were lower for the HARPDN subgroup analysis.

Halgrimson et al. [@b0085] published a highly-powered review of 37 articles with \>9000 patients in 2009, although it was not limited to comparative studies like our present study. It found a statistically significant difference in our primary outcome, conversion to open procedure in favour of HALDN (0.4% vs 0.8%, *P* = 0.015). The pooled cohort in the present study showed no statistical difference in conversion rates (1.88% vs 1.85%, *P* = 0.88). They also found a statistically significant increase in intraoperative events rate for LDN (5.2% vs 2%, *P* \< 0.001). This was not reproduced in our present study (4.54% LDN vs 3.23% HALDN, *P* = 0.27).

Strengths and weaknesses of the study {#s0110}
-------------------------------------

One of the strengths of the present meta-analysis is that it includes a substantial number of studies, with 24 in total. The study provides an updated and thorough analysis of some of the important perioperative outcomes associated with DN. The methodological quality was assessed by two independent reviewers using validated criteria. Broad search terms were used to identify the totality of evidence. A robust methodology was followed to screen and select studies. RCTs were analysed separately to cohort studies at all times. In addition to an overall assessment, subgroup analysis on HARPDN was also carried out.

There are also limitations to the present study. Firstly, there were only three RCTS and one randomised pilot study, which were lowly powered in all but one study. It was, therefore, not possible to perform a sensitivity analysis on RCTs. The main weight of the results has come from cohort studies. There was a high risk of bias for two of the RCTs [@b0120], [@b0135]. Whilst the risk of bias was lower for the other two randomised studies; there were still aspects that were judged unclear. Only three cohort studies were deemed high quality [@b0140], [@b0170], [@b0190]. It would have been preferable to analyse graft survival, postoperative pain scores, and analgesia requirement, but these were poorly reported. Finally, there was significant characteristic and statistical heterogeneity between studies as evidenced by sensitivity analysis accounting for studies from 2010 or later.

Clinical/policy implications {#s0115}
----------------------------

Both HALDN and purely LDN techniques are generally safe and the differences between them are negligible. HALDN has consistently shown to have a shorter WIT than pure LDN. Whilst it is desirable to minimise WIT, previous studies including the Cochrane Review 2011 have shown that laparoscopic techniques having a longer WIT has not had a significant detrimental effect on graft survival [@b0065]. The difference in OT ranged from being negligible in the analysis of RCTs to \>1 h in the HARPDN subgroup. Experience, learning curve, and frequency of case load are obvious factors that may influence the duration of a procedure but other factors, such as coordination with the recipient transplant procedure are not explicitly addressed. Based on the findings of our present study, the risk of intraoperative events and requirement to convert to an open procedure for both techniques was lower than in previous studies. EBL and LOS postoperatively should not influence procedure choice. As one technique cannot be advocated over another it is left to personal preference for the operating surgeon. A retroperitoneoscopic approach may be advantageous in the setting of previous abdominal surgery with potential adhesions. Finally, as major complications in DN are relatively rare, it is important to set up an international register of conversions, intraoperative events, and major postoperative complications, as this is the only way to truly determine safety in minimally invasive DN.

Areas for further research {#s0120}
--------------------------

As DN should minimise the harm to the patient and maximise potential for a quick recovery, further research into other minimally invasive techniques is warranted and is already being carried out. Robot-assisted LDN (RALDN) was first described in 2001/2002 [@b0255], [@b0260]. It has reported good results with no difference in complications or early graft function [@b0265], with the benefit proposed of even earlier discharge from hospital [@b0270]. There have been no RCTs comparing RALDN to other techniques and these higher-level studies would be recommended. Further emerging techniques have shown promising results such as the laparoendoscopic single site (LESS LDN) technique [@b0275] and natural orifice DN [@b0280]. Other areas of research that would be of benefit relate to cost analysis and quality-of-life outcomes using uniform assessment tools.

Conclusion {#s0125}
==========

The present systematic review with meta-analysis has found that there is no major difference between HALDN and pure LDN techniques in terms of perioperative outcomes. There is no statistical difference between the two groups in the rates of conversion to an open procedure and perioperative complications. The hand-assisted method has consistently been shown to have a shorter WIT and duration of procedure. Further studies of higher level of evidence are required to further establish any benefit of one technique over the other.
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[^1]: HALDN: Hand-assisted laparoscopic donor nephrectomy.

[^2]: LDN: Laparoscopic donor nephrectomy.

[^3]: HARPDN: Hand-assisted retroperitoneoscopic donor nephrectomy.

[^4]: RLDN: Retroperitoneal laparoscopic donor nephrectomy.

[^5]: 0--3 low quality; 4--6 medium quality; 7--9 high quality.
